Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT00600236
  4. Details
NCT00600236 Clinical Trial

HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Diabetes Mellitus Type 2 Clinical Trial

Official title:
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00600236
Other study ID # APEC-0018
Secondary ID
Status Completed
Phase Phase 3
First received June 30, 2006
Last updated January 23, 2008
Start date September 2004
Est. completion date January 2008

Study information
Verified date January 2008
Source Asociación para Evitar la Ceguera en México
Contact n/a
Is FDA regulated No
Health authority Mexico: Secretaria de Salud
Study type Interventional

Clinical Trial Summary

One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.

Recruitment information / eligibility
Status Completed
Enrollment 300
Est. completion date January 2008
Est. primary completion date January 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy

- Diabetes mellitus type 2 with 10 years of diagnosis and proliferative retinopathy

Exclusion Criteria:

- Systemic hipertension

- Cardic disease

- Lupus

- Any kind of artritis

- Allergies

- Optic Neuritis

- VKH

- Cancer

- Inmunological diseases

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Intervention

Procedure:
• blood sample

Locations
Country Name City State
Mexico Asociación para Evitar la Ceguera en México, Hospital "Luis Sanchez Bulnes" Mexico City Mexico DF

Sponsors (2)
Lead Sponsor Collaborator
Asociación para Evitar la Ceguera en México Instituto Nacional de Referencia Epidemiológica (INdRE)

Country where clinical trial is conducted

Mexico, 

See also
  Status Clinical Trial Phase
Completed NCT01267448 - Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Phase 4
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Terminated NCT02373865 - Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes Phase 4
Completed NCT01741181 - Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2 Phase 4
Completed NCT01305434 - Mulberry Leaf Extract and Blood Glucose Control in Diabetics Phase 1/Phase 2
Completed NCT01330121 - Bridging the Gap by Transitional Care N/A
Recruiting NCT00992797 - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity Phase 2
Completed NCT01580904 - Impact of Pharmaceutical Care in Diabetics Patients N/A
Active, not recruiting NCT00728403 - Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes Phase 2
Completed NCT00763815 - GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone Phase 3
Active, not recruiting NCT00529815 - Continuous Glucose Monitoring in Patients With Type 2 Diabetes Phase 4
Completed NCT00517465 - A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. Phase 1
Active, not recruiting NCT00417716 - Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema Phase 3
Completed NCT00119041 - Diabetes Telemedicine Consultation: A Systems Improvement Intervention N/A
Active, not recruiting NCT05887635 - Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus N/A
Completed NCT03903965 - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed NCT02666924 - Cooking Classes for Chinese Canadian Patients Living With Diabetes N/A
Recruiting NCT02501850 - The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) Phase 4
Completed NCT02318797 - Optimizing Behavioral Health Homes for Adults With Serious Mental Illness N/A